IP Library Granted Patent US 7,208,583
Granted Patent B2
US 7,208,583 · App. 10/629,951 · Granted Apr 24, 2007

Antibodies immunologically specific for a DNA repair endonuclease and methods of use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,208,583
App. No.
10/629,951
Granted
Apr 24, 2007
Kind
B2
Abstract

An isolated nucleic acid molecule encoding a human DNA repair enzyme, MED1, is disclosed. Like other mismatch repair genes which are mutated in certain cancers, MED1, encoding nucleic acids, proteins and antibodies thereto may be used to advantage in genetic or cancer screening assays. MED1, which recognizes and cleaves DNA, may also be used for the diagnostic detection of mutations and genetic variants.

Claims (4)

1. An isolated antibody immunologically specific for an human methyl-CpG binding endonuclease 1 (MED1) protein of SEQ ID NO: 2.

2. The antibody as claimed in claim 1 , said antibody being monoclonal.

3. The antibody as claimed in claim 1 , said antibody being polyclonal.

4. An isolated antibody fragment immunologically specific for a methyl-CpG binding endonuclease 1 (MED1) protein of SEQ ID NO: 2, said fragment being selected from the group consisting of Fab fragment, Fv fragment, F(ab′)2 fragment, and single chains Fv fragment.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2020
From: THE FOX CHASE CANCER CENTER FOUNDATION
To: THE INSTITUTE FOR CANCER RESEARCH
Reel/Frame 053562/0938 →